The Point of Care is a new approach for which drugs production sites should be as much close as possible to patients, to reduce the product lead.
Vaccine Technology Transfer is a core challenge for pharmaceutical companies that are involved in the fight to Covid-19.
The insight discuss the updated safety assessment of the food additive titanium dioxide (E 171) and experts concerns.
Find out from PQE experts how to perform a strong technology transfer to boost your vaccines production and meet compliance standards.
Covid-19 impacts the daily routine of Pharma manufacturers, raising new challenges for employees’ safety and products’ quality.
Manufacturers of API and finished products should cooperate with MAHs to prevent nitrosamine formation and contamination of human medicinal products.
